Sareum Holdings plc Announces Issuance of 85,000 New Shares Following Warrant Exercise at 12.5p

Sareum Holdings plc Announces Issuance of 85,000 New Shares Following Warrant Exercise at 12.5p →

Sareum Holdings plc (AIM: SAR), the Cambridge-based clinical-stage biotech firm specializing in next-generation kinase inhibitors for autoimmune diseases and cancer, has revealed that warrant holders exercised their rights to subscribe for…